Piper Sandler & Co’s Celgene Corp CELG Stock Holding History

Piper Sandler & Co’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-2,200	Closed	-$154K	–	178
2014 Q1	$154K	Buy	+2,200	New	+$174K	0.13%	82

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Piper Sandler & Co's CELG Position: Q2 2014 in Review

Piper Sandler & Co sold out of Celgene Corp (CELG) in Q2 2014, closing a stake of 2,200 shares — an estimated $154K sold.

Piper Sandler & Co first reported a position in CELG in Q1 2014 and held it in 1 quarter. The position peaked at $154K in Q1 2014. 995 funds tracked by Wall St. Rank hold CELG as of Q2 2014.

Piper Sandler & Co reported no remaining Celgene Corp position as of Q2 2014 after selling out during the quarter.
Piper Sandler & Co sold 2,200 Celgene Corp shares in Q2 2014, an estimated $154K.
Piper Sandler & Co first reported a position in Celgene Corp in Q1 2014 and held it in 1 quarter.
Piper Sandler & Co's Celgene Corp position peaked at $154K in Q1 2014.
995 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2014.

Based on Piper Sandler & Co's 13F filing for Q2 2014, filed 14 Aug 2014.